Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael

TMFSaintCroix

Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles

602a3273222683f6ad6810d6_ARC

Nano-X Imaging Receives FDA Clearance for X-Ray Device

The company will start shipping its X-ray machines to hospitals in the fourth quarter of 2021.


GettyImages-1278530606

2 Biotech Stocks That Could Be Millionaire Makers

Why OptimizeRx and Ontrak might make you rich.


female pharmacist holds a bottle of medication

2 Great Stocks Under $10 per Share

Amarin and Accelerate Diagnostics are healthcare companies with significant upside.


GettyImages-539282157 (1)

Is Chuy's Stock a Buy?

This restaurant stock is up 47% in 2021 and up an amazing 270% from a year ago. Why is Chuy's stock doing so well, and will it continue?


GettyImages-949947128

Cathie Wood Owns Schrodinger Stock: Should You?

Wood's biotech fund owns almost $200 million worth of Schrodinger, about 2% of the company. Here's why she's an investor.

GettyImages-1272904662

If I Had $5,000, This Is How I'd Invest It

I'd increase my stakes in two small caps that I already own.


SPACs-_Why_Are_They_On_Fire_Right_Now

SPACs: Why Are They On Fire Right Now?

More and more tech companies are avoiding the IPO and using a SPAC to come public. What's going on?


Biotech_Stocks-_What_Will_2021_Look_Like-2

Biotech Stocks: What Will 2021 Look Like?

2020 was a wild run for the biotech sector, with COVID-19 dominating the headlines. What will happen this year?


3_Unstoppable_Healthcare_Stocks_To_Buy_On_The_Dip

3 Unstoppable Healthcare Stocks to Buy on the Dip

Intuitive Surgical, Teladoc Health, and Veeva Systems all have fantastic opportunities and should make investors a lot of money over the next decade.


2_Hot_SPACs_Investors_Should_Watch

2 Hot SPACs Investors Should Watch

23andMe and Butterfly Networks are two private biotech companies hitting the public markets soon.

Why_You_Want_To_Own_Biotech_Stocks_Now

Why You Should Own Biotech Stocks Now

The confluence of healthcare and technology will send many biotech stocks soaring over the next decade.


What_Are_the_Risks_of_Investing_In_Biotech_Stocks

What Are the Risks of Investing in Biotech Stocks?

The sector has incredible upside over the next decade. How should investors approach this market opportunity?


1_Green_Flag_For_Axsome_Therapeutics

1 Green Flag for Axsome Therapeutics

The upstart biotech is filing two new drug applications in 2021, and has several more on the way.


What_Are_Novavax_s_Long-term_Prospects

What Are Novavax's Long-Term Prospects?

It's shifting from an unprofitable biotech to a company collecting billions in revenue.


Is_Nano-X_a_Buy

Is Nano-X a Buy?

This healthcare disrupter is about to receive FDA clearance to start distributing its new X-ray device.

4 SPACs for the Future

A rocket company, a 3-D capture software company, and two biotechs are about to hit the public markets. Smart investors can get in now via special purpose acquisition companies.


GettyImages-542739361

Nano-X Imaging: Buy the Dip?

The X-ray disrupter is almost 50% off its highs.


1_Under-the-Radar_Stock_For_Healthcare_Investors_To_Buy_Now

1 Under-the-Radar Stock For Healthcare Investors to Buy Now

OptimizeRx is disrupting the pharmaceutical sales call with an internet option for marketing drugs to doctors.


What_s_the_Strongest_Buy_Moderna,_Teladoc_Health,_or_Fulgent_Genetics

What's the Strongest Buy: Moderna, Teladoc Health, or Fulgent Genetics?

All three of these stocks have had incredible spikes because of COVID-19. One stock, however, is a safer and stronger long-term investment.


1_Green_Flag_for_Fulgent_Genetics

1 Green Flag for Fulgent Genetics

Here's why Fulgent stock is running so high.